The development of more recently approved drugs that cannot be tested as monotherapy
precludes assessment of the impact of resistance on antiretroviral activity that is not seriously …

Resistance to antiretroviral drugs remains an important limitation to successful human
immunodeficiency virus type 1 (HIV-1) therapy. Resistance testing can improve treatment …

Antiretroviral-therapy rollout in resource-poor countries is often associated with limited, if any,
HIV-RNA monitoring. The effect of variable monitoring on the emergence of resistance …

In evaluating current combination drug regimens for treatment of human immunodeficiency
virus (HIV) disease, it is important to determine the existence of viral reservoirs. After …

BACKGROUND & AIMS: Hepatitis C virus (HCV) induces chronic infection in 50% to 80% of
infected persons; approximately 50% of these do not respond to therapy. We performed a …

Context New trial data and drug regimens that have become available in the last 2 years
warrant an update to guidelines for antiretroviral therapy (ART) in human immunodeficiency …

Context Recent data regarding the consequences of untreated human immunodeficiency
virus (HIV) infection and the expansion of treatment choices for antiretroviral-naive and …

Importance New data and therapeutic options warrant updated recommendations for the
use of antiretroviral drugs (ARVs) to treat or to prevent HIV infection in adults. Objective To …

Importance Recent advances in treatment and prevention of HIV warrant updated
recommendations to guide optimal practice. Objective Based on a critical evaluation of new data, to …

Importance Antiretroviral therapy (ART) is the cornerstone of prevention and management
of HIV infection. Objective To evaluate new data and treatments and incorporate this …